menu
    • menu

    Company profile for HuidaGene Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HuidaGene Biotechnology Co., Ltd (辉大基因) is a global biotechnology company focusing on the discovering, engineering, and developing CRISPR-based genetic medicine to rewrite the future of genomic medicine. Based in Shanghai and New Jersey, HuiGene is committed to addressing patient's needs globally with various preclinical therapeutic programs covering ophthalmology, otology, myology, and neurology. Company's CRISP...
    HuidaGene Biotechnology Co., Ltd (辉大基因) is a global biotechnology company focusing on the discovering, engineering, and developing CRISPR-based genetic medicine to rewrite the future of genomic medicine. Based in Shanghai and New Jersey, HuiGene is committed to addressing patient's needs globally with various preclinical therapeutic programs covering ophthalmology, otology, myology, and neurology. Company's CRISPR-based therapeutics offer the potential to cure patients with life-threatening conditions by repairing the cause of their disease. We are committed to transform the future of genome-editing medicine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HuidaGene TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    2nd Floor, Unit 3, Building 5 No. 160 Basheng Road, Pudong New Area Shanghai
    Telephone
    Telephone
    021-80118181
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.huidagene.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/huidagene/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Huidagene Announces First Patient Dosed In Multinational Ph 1/2 Trial Of Hg004
    Huidagene Announces First Patient Dosed In Multinational Ph 1/2 Trial Of Hg004

    01 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/huidagene-therapeutics-announces-first-patient-dosed-in-multinational-phase-12-trial-of-hg004-for-inherited-blindness-301974277.html

    PR NEWSWIRE
    01 Nov 2023
    Share Share
    Huidagene Receives FDA Rare Pediatric Disease Designation For Hg004
    Huidagene Receives FDA Rare Pediatric Disease Designation For Hg004

    07 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/huidagene-therapeutics-receives-fda-rare-pediatric-disease-designation-for-hg004-to-treat-inherited-blindness-301894514.html

    PR NEWSWIRE
    07 Aug 2023
    Share Share
    HUIDAGENE ANNOUNCES IND APPROVAL OF THE FIRST CHINA MULTI-REGIONAL
    HUIDAGENE ANNOUNCES IND APPROVAL OF THE FIRST CHINA MULTI-REGIONAL

    18 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/huidagene-announces-ind-approval-of-the-first-china-multi-regional-multi-national-master-protocol-of-hg004-by-nmpa-301800075.html

    PR NEWSWIRE
    18 Apr 2023
    Share Share
    HuidaGene Appoints New Members to the Scientific Advisory Board
    HuidaGene Appoints New Members to the Scientific Advisory Board

    10 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/huidagene-appoints-new-members-to-the-scientific-advisory-board-301792898.html

    PR NEWSWIRE
    10 Apr 2023
    Share Share
    HuidaGene Receives Orphan Drug Designation for Gene Therapy of Blindness
    HuidaGene Receives Orphan Drug Designation for Gene Therapy of Blindness

    03 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/huidagene-receives-orphan-drug-designation-for-gene-therapy-of-blindness-301787815.html

    PR NEWSWIRE
    03 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search